Serving Australia and NZ
1300 543 373

Pathway Inhibitors

Loading...

Items 1-30 of 5370

Set Descending Direction
Page
per page

Product Name

Product Number

Supplier

Size

Protease Inhibitor Cocktail (100x strength) PIC02 Cytoskeleton 1 x 1 ml
Cell Permeable Rho Inhibitor (C3 Trans based)) CT04-C Cytoskeleton 20 x 20 µg
Cell Permeable Rho Inhibitor (C3 Trans based)) CT04-B Cytoskeleton 5 x 20 µg
Cell Permeable Rho Inhibitor (C3 Trans based)) CT04-A Cytoskeleton 1 x 20 µg
Trypsin Inhibitor (7000 BAEE Units of inhibition/mg material) TIN-03 Alpha Diagnostic 5 g
Trypsin Inhibitor (20000 BAEE Units of inhibition/mg material) TIN-02 Alpha Diagnostic 1 g
Trypsin Inhibitor (10000 BAEE Units of inhibition/mg material) TIN-01 Alpha Diagnostic 5 g
Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) SM-101130-5 Alpha Diagnostic 5 mg
Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) SM-101130-25 Alpha Diagnostic 25 mg
Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) SM-101120-5 Alpha Diagnostic 5 mg
Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) SM-101120-25 Alpha Diagnostic 25 mg
Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) SM-101110-50 Alpha Diagnostic 50 mg
Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) SM-101110-10 Alpha Diagnostic 10 mg
AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) SM-101100-5 Alpha Diagnostic 5 mg
AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) SM-101100-25 Alpha Diagnostic 25 mg
AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) SM-101090-5 Alpha Diagnostic 5 mg
AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) SM-101090-25 Alpha Diagnostic 25 mg
CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) SM-101080-5 Alpha Diagnostic 5 mg
CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) SM-101080-25 Alpha Diagnostic 25 mg
Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) SM-101070-50 Alpha Diagnostic 50 mg
Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) SM-101070-10 Alpha Diagnostic 10 mg
Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) SM-101060-25 Alpha Diagnostic 25 mg
Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) SM-101060-100 Alpha Diagnostic 100 mg
Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) SM-101050-100 Alpha Diagnostic 100 mg
Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) SM-101050-10 Alpha Diagnostic 10 mg
Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 5574; >98%) SM-101040-5 Alpha Diagnostic 5 mg
Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 5574; >98%) SM-101040-25 Alpha Diagnostic 25 mg
Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) SM-101030-25 Alpha Diagnostic 25 mg
Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) SM-101030-100 Alpha Diagnostic 100 mg
Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) SM-101020-50 Alpha Diagnostic 50 mg

Items 1-30 of 5370

Set Descending Direction
Page
per page